Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-26

Clinical Trial Update: Intranasal Nafarelin For Triggering Oocyte Maturation [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating intranasal nafarelin to trigger oocyte maturation in fertility disorders, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nafarelin nasal spray (Nafarelin)

Snippet

Sponsor: Fundacion Dexeus | Conditions: Fertility Disorders | Phase 4 | Status: NOT_YET_RECRUITING